Prevalence and impact of germline mutations in pancreatic ductal adenocarcinoma
Our findings confirm the relevance of multigene panel testing in PDAC and reveal a germline mutation spectrum consistent with global data. These results support universal germline screening and emphasize the need for continued VUS interpretation, particularly in genomically understudied populations.
Authors
- Taha Reşid ÖZDEMİR
- Özge Özer Kaya (ORCID: https://orcid.org/0000-0001-6731-2461)
- Emir Gökhan Kahraman (ORCID: https://orcid.org/0000-0001-5303-6590)
- Olçun Ümit Ünal (ORCID: https://orcid.org/0000-0001-7698-3574)
- Selcan Keşan
Institutions
- Izmir University (TR)
- Dokuz Eylül University (TR)
Publication Details
- Journal
- Tumori Journal
- Published
- 2026-01-22
- DOI
- https://doi.org/10.1177/03008916251410475
- Primary Topic
- Pancreatic and Hepatic Oncology Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00